Plasma metabolomic and lipidomic alterations associated with anti-tuberculosis drug-induced liver injury

Background: Anti-tuberculosis drug-induced liver injury (ATB-DILI) is an adverse reaction with a high incidence and the greatest impact on tuberculosis treatment. However, there is a lack of effective biomarkers for the early prediction of ATB-DILI. Herein, this study uses UPLC‒MS/MS to reveal the p...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ming-Gui, Wu, Shou-Quan, Zhang, Meng-Meng, He, Jian-Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641415/
https://www.ncbi.nlm.nih.gov/pubmed/36386176
http://dx.doi.org/10.3389/fphar.2022.1044808

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641415/
https://www.ncbi.nlm.nih.gov/pubmed/36386176
http://dx.doi.org/10.3389/fphar.2022.1044808

Ejemplares similares